Abstract
Mucocutaneous leishmaniasis (MCL) is endemic in the tropical Amazonian lowlands of Bolivia, an area that regularly receives influxes of migratory populations. In these new agricultural development areas, a campaign to diagnose and treat the disease was carried out between 1989 and 1992, in order to provide direct access to MCL treatment in the endemic areas at a standard equivalent to that offered in the urban centres in Bolivia. The campaign led to the creation of decentralized local centres for diagnosis and treatment of the disease. A campaign to inform the population about leishmaniasis was also undertaken and courses were run to educate medical and paramedical personnel. As a result of the campaign, 3285 cases of leishmaniasis were diagnosed, including 2152 cutaneous and 326 mucosal forms. Also, a total of 1888 cases were treated, 1677 of which cutaneous and 211, mucosal.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- David C., Dimier-David L., Vargas F., Torrez M., Dedet J. P. Fifteen years of cutaneous and mucocutaneous leishmaniasis in Bolivia: a retrospective study. Trans R Soc Trop Med Hyg. 1993 Jan-Feb;87(1):7–9. doi: 10.1016/0035-9203(93)90398-a. [DOI] [PubMed] [Google Scholar]
- Dimier-David L., David C., Muñoz M., Vargas F., Bustillos R., Valda L., Dedet J. P. Particularités épidémiologiques, cliniques et biologiques de la leishmaniose cutanéo-muqueuse en Bolivie d'après un échantillon de 221 malades. Bull Soc Pathol Exot. 1993;86(2):106–111. [PubMed] [Google Scholar]
- Dimier-David L., David C., Ravisse P., Bustillos R., Revollo S., Lyèvre P., Muñoz M., Vargas F., Dedet J. P. Parasitological diagnosis of mucocutaneous leishmaniasis due to Leishmania b. braziliensis in Bolivia. Rev Soc Bras Med Trop. 1991 Oct-Dec;24(4):231–234. doi: 10.1590/s0037-86821991000400005. [DOI] [PubMed] [Google Scholar]
- Franke E. D., Wignall F. S., Cruz M. E., Rosales E., Tovar A. A., Lucas C. M., Llanos-Cuentas A., Berman J. D. Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis. Ann Intern Med. 1990 Dec 15;113(12):934–940. doi: 10.7326/0003-4819-113-12-934. [DOI] [PubMed] [Google Scholar]
- Herwaldt B. L., Berman J. D. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg. 1992 Mar;46(3):296–306. doi: 10.4269/ajtmh.1992.46.296. [DOI] [PubMed] [Google Scholar]
- Marinkelle C. J. The control of leishmaniases. Bull World Health Organ. 1980;58(6):807–818. [PMC free article] [PubMed] [Google Scholar]
- Marsden P. D. Mucosal leishmaniasis ("espundia" Escomel, 1911). Trans R Soc Trop Med Hyg. 1986;80(6):859–876. doi: 10.1016/0035-9203(86)90243-9. [DOI] [PubMed] [Google Scholar]
- Marsden P. D., Sampaio R. N., Carvalho E. M., Veiga J. P., Costa J. L., Llanos-Cuentas E. A. High continuous antimony therapy in two patients with unresponsive mucosal leishmaniasis. Am J Trop Med Hyg. 1985 Jul;34(4):710–713. doi: 10.4269/ajtmh.1985.34.710. [DOI] [PubMed] [Google Scholar]
- Revollo S., Dimier-David L., David C., Lyevre P., Camacho C., Dedet J. P. Isoenzyme characterization of Leishmania braziliensis braziliensis isolates obtained from Bolivian and Peruvian patients. Trans R Soc Trop Med Hyg. 1992 Jul-Aug;86(4):388–391. doi: 10.1016/0035-9203(92)90231-z. [DOI] [PubMed] [Google Scholar]
- Saf'janova V. M. Leishmaniasis control. Bull World Health Organ. 1971;44(4):561–566. [PMC free article] [PubMed] [Google Scholar]
- Torres Espejo J. M., Le Pont F., Mouchet J., Desjeux P., Richard A. Epidémiologie de la leishmaniose tégumentaire en Bolivie. 1. Description des zones d'étude et fréquence de la maladie. Ann Soc Belg Med Trop. 1989 Dec;69(4):297–306. [PubMed] [Google Scholar]